Akero Therapeutics Stock Technical Analysis

AKRO Stock  USD 45.24  0.16  0.35%   
As of the 26th of March, Akero Therapeutics shows the mean deviation of 4.25, and Risk Adjusted Performance of 0.0831. Akero Therapeutics technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Akero Therapeutics Momentum Analysis

Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Akero, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to Akero
  
Akero Therapeutics' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.

Akero Therapeutics Analyst Consensus

Target PriceAdvice# of Analysts
48.27Strong Buy11Odds
Akero Therapeutics current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Akero analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Akero stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Akero Therapeutics, talking to its executives and customers, or listening to Akero conference calls.
Akero Analyst Advice Details
Akero Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Akero Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Akero Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Akero Therapeutics Technical Analysis

Indicator
Time Period
Execute Indicator
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Akero Therapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.

Akero Therapeutics Trend Analysis

Use this graph to draw trend lines for Akero Therapeutics. You can use it to identify possible trend reversals for Akero Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Akero Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.

Akero Therapeutics Best Fit Change Line

The following chart estimates an ordinary least squares regression model for Akero Therapeutics applied against its price change over selected period. The best fit line has a slop of   0.39  , which means Akero Therapeutics will continue generating value for investors. It has 122 observation points and a regression sum of squares at 5612.26, which is the sum of squared deviations for the predicted Akero Therapeutics price change compared to its average price change.

About Akero Therapeutics Technical Analysis

The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Akero Therapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Akero Therapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Akero Therapeutics price pattern first instead of the macroeconomic environment surrounding Akero Therapeutics. By analyzing Akero Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Akero Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Akero Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
 2022 2023 2024 2025 (projected)
Current Ratio18.6129.2719.3814.62
Net Debt To EBITDA2.151.41.192.1

Akero Therapeutics March 26, 2025 Technical Indicators

Most technical analysis of Akero help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Akero from various momentum indicators to cycle indicators. When you analyze Akero charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

Akero Therapeutics March 26, 2025 Daily Trend Indicators

Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Akero stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
When determining whether Akero Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Akero Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Akero Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Akero Therapeutics Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Akero Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
To learn how to invest in Akero Stock, please use our How to Invest in Akero Therapeutics guide.
You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Akero Therapeutics. If investors know Akero will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Akero Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.75)
Return On Assets
(0.25)
Return On Equity
(0.39)
The market value of Akero Therapeutics is measured differently than its book value, which is the value of Akero that is recorded on the company's balance sheet. Investors also form their own opinion of Akero Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Akero Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Akero Therapeutics' market value can be influenced by many factors that don't directly affect Akero Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Akero Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Akero Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Akero Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.